Expression of a Dominant-negative Mutant TGF-beta Type II Receptor in Transgenic Mice Reveals Essential Roles for TGF-beta in Regulation of Growth and Differentiation in the Exocrine Pancreas

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1997 May 15

PMID 9184209

Citations 84

Authors

E P Bottinger

J L Jakubczak

I S Roberts

M Mumy

P Hemmati

K Bagnall

G Merlino

L M Wakefield

Affiliations

Soon will be listed here.

Abstract

Using a dominant-negative mutant receptor (DNR) approach in transgenic mice, we have functionally inactivated transforming growth factor-beta (TGF-beta) signaling in select epithelial cells. The dominant-negative mutant type II TGF-beta receptor blocked signaling by all three TGF-beta isoforms in primary hepatocyte and pancreatic acinar cell cultures generated from transgenic mice, as demonstrated by the loss of growth inhibitory and gene induction responses. However, it had no effect on signaling by activin, the closest TGF-beta family member. DNR transgenic mice showed increased proliferation of pancreatic acinar cells and severely perturbed acinar differentiation. These results indicate that TGF-beta negatively controls growth of acinar cells and is essential for the maintenance of a differentiated acinar phenotype in the exocrine pancreas in vivo. In contrast, such abnormalities were not observed in the liver. Additional abnormalities in the pancreas included fibrosis, neoangiogenesis and mild macrophage infiltration, and these were associated with a marked up-regulation of TGF-beta expression in transgenic acinar cells. This transgenic model of targeted functional inactivation of TGF-beta signaling provides insights into mechanisms whereby loss of TGF-beta responsiveness might promote the carcinogenic process, both through direct effects on cell proliferation, and indirectly through up-regulation of TGF-betas with associated paracrine effects on stromal compartments.

Citing Articles

The Role of the Pancreatic Extracellular Matrix as a Tissue Engineering Support for the Bioartificial Pancreas.

Santos da Silva T, da Silva-Junior L, Horvath-Pereira B, Valbao M, Garcia M, Lopes J Biomimetics (Basel). 2024; 9(10).

PMID: 39451804 PMC: 11505355. DOI: 10.3390/biomimetics9100598.

TGF-β signaling in health, disease, and therapeutics.

Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.

PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.

Krüppel-like Factor 5 Plays an Important Role in the Pathogenesis of Chronic Pancreatitis.

Alavi M, Mejia-Bautista A, Tang M, Bandovic J, Rosenberg A, Bialkowska A Cancers (Basel). 2023; 15(22).

PMID: 38001687 PMC: 10670257. DOI: 10.3390/cancers15225427.

Intrapancreatic fat, pancreatitis, and pancreatic cancer.

Lilly A, Astsaturov I, Golemis E Cell Mol Life Sci. 2023; 80(8):206.

PMID: 37452870 PMC: 10349727. DOI: 10.1007/s00018-023-04855-z.

TGF-β Signaling in Progression of Oral Cancer.

Guo Y, Xu T, Chai Y, Chen F Int J Mol Sci. 2023; 24(12).

PMID: 37373414 PMC: 10299206. DOI: 10.3390/ijms241210263.

References

Bockman D . Cells of origin of pancreatic cancer: experimental animal tumors related to human pancreas. Cancer. 1981; 47(6 Suppl):1528-34. DOI: 10.1002/1097-0142(19810315)47:6+<1528::aid-cncr2820471415>3.0.co;2-x. View

Hsing A, Kadomatsu K, Bonham M, Danielpour D . Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res. 1996; 56(22):5146-9. View

Scarpelli D, Rao M, Reddy J . Studies of pancreatic carcinogenesis in different animal models. Environ Health Perspect. 1984; 56:219-27. PMC: 1568204. View

Roberts A, Sporn M, Assoian R, Smith J, Roche N, Wakefield L . Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986; 83(12):4167-71. PMC: 323692. DOI: 10.1073/pnas.83.12.4167. View

Ornitz D, Hammer R, Messing A, Palmiter R, Brinster R . Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science. 1987; 238(4824):188-93. DOI: 10.1126/science.2821617. View

Flanders K, Thompson N, Cissel D, Van Obberghen-Schilling E, Baker C, Kass M . Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol. 1989; 108(2):653-60. PMC: 2115454. DOI: 10.1083/jcb.108.2.653. View

Pierce G, Mustoe T, Lingelbach J, Masakowski V, Griffin G, Senior R . Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989; 109(1):429-40. PMC: 2115493. DOI: 10.1083/jcb.109.1.429. View

Bascom C, Wolfshohl J, Coffey Jr R, Madisen L, Webb N, Purchio A . Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol. 1989; 9(12):5508-15. PMC: 363721. DOI: 10.1128/mcb.9.12.5508-5515.1989. View

de Lisle R, Logsdon C . Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur J Cell Biol. 1990; 51(1):64-75. View

10.

Sandgren E, Luetteke N, Palmiter R, Brinster R, Lee D . Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990; 61(6):1121-35. DOI: 10.1016/0092-8674(90)90075-p. View

11.

Flanders K, Cissel D, Mullen L, Danielpour D, Sporn M, Roberts A . Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays. Growth Factors. 1990; 3(1):45-52. DOI: 10.3109/08977199009037501. View

12.

Sandgren E, Quaife C, Paulovich A, Palmiter R, Brinster R . Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A. 1991; 88(1):93-7. PMC: 50755. DOI: 10.1073/pnas.88.1.93. View

13.

Millan F, Denhez F, Kondaiah P, Akhurst R . Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development. 1991; 111(1):131-43. DOI: 10.1242/dev.111.1.131. View

14.

Logsdon C, Keyes L, Beauchamp R . Transforming growth factor-beta (TGF-beta 1) inhibits pancreatic acinar cell growth. Am J Physiol. 1992; 262(2 Pt 1):G364-8. DOI: 10.1152/ajpgi.1992.262.2.G364. View

15.

Oberhammer F, Pavelka M, Sharma S, Tiefenbacher R, Purchio A, Bursch W . Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A. 1992; 89(12):5408-12. PMC: 49301. DOI: 10.1073/pnas.89.12.5408. View

16.

Jacks T, Fazeli A, Schmitt E, Bronson R, Goodell M, Weinberg R . Effects of an Rb mutation in the mouse. Nature. 1992; 359(6393):295-300. DOI: 10.1038/359295a0. View

17.

Bockman D, Merlino G . Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology. 1992; 103(6):1883-92. DOI: 10.1016/0016-5085(92)91448-d. View

18.

Wrana J, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M . TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 1992; 71(6):1003-14. DOI: 10.1016/0092-8674(92)90395-s. View

19.

Chen R, Ebner R, Derynck R . Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science. 1993; 260(5112):1335-8. DOI: 10.1126/science.8388126. View

20.

Brand T, Maclellan W, Schneider M . A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J Biol Chem. 1993; 268(16):11500-3. View